Allegra Allergy Tablet, Coated
Product Images NDC 41167-4122

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Allegra Allergy (NDC 41167-4122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chattem, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 41167-4122-0allegra® Allergyfexofenadine Hci Tablets180 mg/antihistamine24 Hr8 Gelcaps (Allegra Gelcaps 01)

Allegra Allergy 180 mg coated tablets packaging label for oral use by Chattem, Inc. It includes 8 gelcaps formulated with fexofenadine hydrochloride for 24-hour allergy relief. The label highlights non-drowsy effects and relief of indoor/outdoor allergy symptoms such as sneezing, runny nose, itchy and watery eyes, and itchy nose or throat. The front panel shows the brand and dosage prominently with a blue and purple gradient background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.